Most strikingly, treatment with Mito+ CAR T cells improved overall survival of NXG mice bearing acute lymphoblastic leukemia in comparison to Mito- CAR T cells or monocultured aCD19-CAR CD8 cells. Here, CD8A is linked to acute lymphoblastic leukemia.